Ondine Biomedical Names Alan Thomas as Interim CFO

 

Ondine Biomedical Inc. (LSE:OBI) has appointed Alan Thomas as its interim Chief Financial Officer, stepping in for Michael Behlke, who has stepped down due to personal reasons. Thomas, who will not join the Board, brings over 25 years of senior financial leadership experience within the healthcare and biotech industries. His previous roles include CFO positions at Maximus Canada Inc. and BC Transit, where he developed a strong track record in financial strategy and corporate governance.

This leadership transition comes at a pivotal time for Ondine, as it continues to scale its innovative photodisinfection technology. Thomas is expected to play a key role in supporting the company’s financial framework during this next stage of expansion.

About Ondine Biomedical Inc.

Headquartered in Canada, Ondine Biomedical Inc. develops and commercializes light-activated antimicrobial therapies under the field of photodisinfection. Its flagship product, the nasal disinfection system Steriwave®, is already approved in Canada and Europe, with ongoing clinical trials in the United States. The company’s platform targets a range of infections, including chronic sinusitis and ventilator-associated pneumonia.

• Average Daily Trading Volume: 153,767

• Technical Sentiment: Sell

• Market Capitalization: £39.89 million

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Ltd. ADVFN Ltd does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Comments are closed

WHAT IS ADVFN?

ADVFN covers all things stock market.

From the news and opinion pieces on pages like this to share discussion forums, charting tools, financials, live share prices and Level 2, order book data

If you trade or invest ADVFN has the tools you need to make the right decisions.

• 

  101 Ways to Pick Stock Market Winners

  You need the number one bestselling investment guide, the definitive text for day traders, investors and stock pickers.

• 

  The Death of Wealth

  Dissecting the global economy and the financial markets, the book lays out the evidence for the next economic game changer: the Death of Wealth.

• 

  Ben Branson

• 

  Clem Chambers

• 

  Tom Clark

• 

  Lou Gutheil